Authors’ Reply to Noguchi et al. Comment on: “Differences in the Adverse Event Profiles of Sodium-Glucose Cotransporter 2 Inhibitors Used in Patients with Diabetes and Heart Failure: An Analysis Using the Japanese Adverse Drug Event Report Database”.

HOME
>
論文・技術情報
>
Authors’ Reply to Noguchi et al. Comment on: “Differences in the Adverse Event Profiles of Sodium-Glucose Cotransporter 2 Inhibitors Used in Patients with Diabetes and Heart Failure: An Analysis Using the Japanese Adverse Drug Event Report Database”.

アブストラクト
ジャーナル名	Clinical drug investigation
Pubmed追加日	2024/12/24
投稿者	Sakamoto, Toshiaki; Miyamoto, Hirotaka; Hashizume, Junya; Akamatsu, Hayato; Akagi, Tomoaki; Kodama, Yukinobu; Hamano, Hirofumi; Zamami, Yoshito; Ohyama, Kaname
組織名	Department of Hospital Pharmacy, Nagasaki University Hospital, 1-7-1 Sakamoto,;Nagasaki City, Nagasaki Prefecture, 852-8501, Japan. sakamoto@nagasaki-u.ac.jp.;Department of Pharmaceutics, Graduate School of Biomedical Sciences, Nagasaki;University, Nagasaki, Japan.;Nagasaki City, Nagasaki Prefecture, 852-8501, Japan.;Department of Pharmacy, Okayama University Hospital, Okayama, Japan.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/39718696/